[Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer].
作者信息
Spohn Simon K B, Grosu Anca-Ligia
机构信息
Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Deutschland.
出版信息
Strahlenther Onkol. 2022 Sep;198(9):869-872. doi: 10.1007/s00066-022-01955-w. Epub 2022 May 17.
Abstract
摘要
相似文献
1
[Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer].
Strahlenther Onkol. 2022 Sep;198(9):869-872. doi: 10.1007/s00066-022-01955-w. Epub 2022 May 17.
2
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer.在局部前列腺癌的随机对照 FLAME 试验中，比较单纯外照射放疗与额外局部加量放疗的失败模式。
Eur Urol. 2022 Sep;82(3):252-257. doi: 10.1016/j.eururo.2021.12.012. Epub 2021 Dec 23.
3
Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.高剂量率前列腺植入后装放疗增敏与适形外照射放疗增敏之间的正常组织剂量学比较：剂量递增的潜力
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8. doi: 10.1016/s0360-3016(99)00501-5.
4
Re: Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: Results from the FLAME Randomized Phase III Trial.回复：局部前列腺癌患者外照射放疗中前列腺内肿瘤的局部增强：FLAME随机III期试验结果
Eur Urol. 2022 May;81(5):544-545. doi: 10.1016/j.eururo.2022.01.015. Epub 2022 Jan 31.
5
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial.标准全前列腺放疗联合或不联合病灶加量放疗治疗前列腺癌：FLAME 随机对照试验中的毒性反应。
Radiother Oncol. 2018 Apr;127(1):74-80. doi: 10.1016/j.radonc.2017.12.022. Epub 2018 Jan 11.
6
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.在 FLAME 试验中，外照射放疗前列腺癌后晚期胃肠道毒性的肛肠剂量效应关系。
Radiother Oncol. 2021 Sep;162:98-104. doi: 10.1016/j.radonc.2021.06.033. Epub 2021 Jun 29.
7
Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.在 FLAME 试验中，外照射放疗治疗前列腺癌后晚期泌尿生殖系统毒性的尿道和膀胱剂量-效应关系。
Radiother Oncol. 2022 Feb;167:127-132. doi: 10.1016/j.radonc.2021.12.027. Epub 2021 Dec 28.
8
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.前瞻性比较有效性研究的 5 年结果，评估局部前列腺癌的外照射放疗联合或不联合低剂量率近距离放疗增敏。
Cancer. 2021 Jun 1;127(11):1912-1925. doi: 10.1002/cncr.33388. Epub 2021 Feb 17.
9
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.雄激素抑制联合选择性淋巴结及剂量递增放射治疗（ASCENDE-RT试验）：一项针对高风险和中风险前列腺癌的随机试验的生存终点分析，该试验比较了低剂量率近距离放疗增敏与剂量递增外照射增敏。
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285. doi: 10.1016/j.ijrobp.2016.11.026. Epub 2016 Nov 24.
10
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.局部前列腺癌外照射放疗中前列腺内肿瘤焦点增强：来自 FLAME 随机 III 期试验的结果。
J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20.
本文引用的文献
1
Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.在 FLAME 试验中，外照射放疗治疗前列腺癌后晚期泌尿生殖系统毒性的尿道和膀胱剂量-效应关系。
Radiother Oncol. 2022 Feb;167:127-132. doi: 10.1016/j.radonc.2021.12.027. Epub 2021 Dec 28.
2
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.醋酸阿比特龙和泼尼松与或不与恩扎卢胺用于高危非转移性前列腺癌：来自 STAMPEDE 平台方案两项随机对照 3 期试验主要结果的荟萃分析。
Lancet. 2022 Jan 29;399(10323):447-460. doi: 10.1016/S0140-6736(21)02437-5. Epub 2021 Dec 23.
3
PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial.基于PSMA-PET/MRI的立体定向体部放射治疗（HypoFocal-SBRT）原发性前列腺癌患者的局部剂量递增：一项随机、多中心III期试验的研究方案
Cancers (Basel). 2021 Nov 18;13(22):5795. doi: 10.3390/cancers13225795.
4
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.前列腺癌影像中的放射组学用于个体化治疗方法——当前方法学的各个方面和已验证研究的系统评价。
Theranostics. 2021 Jul 6;11(16):8027-8042. doi: 10.7150/thno.61207. eCollection 2021.
5
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial.在 FLAME 试验中，外照射放疗前列腺癌后晚期胃肠道毒性的肛肠剂量效应关系。
Radiother Oncol. 2021 Sep;162:98-104. doi: 10.1016/j.radonc.2021.06.033. Epub 2021 Jun 29.
6
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial.高危和极高危前列腺癌的前列腺放疗与全盆腔放疗比较（POP-RT）：来自 III 期随机对照试验的结果。
J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26.
7
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.局部前列腺癌外照射放疗中前列腺内肿瘤焦点增强：来自 FLAME 随机 III 期试验的结果。
J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20.
8
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT（proPSMA）：一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
9
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison.（68）镓-六氮杂环十二烷四乙酸-环糊精-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描与原发性局限性前列腺癌组织病理学的体素级比较
Theranostics. 2016 Jun 18;6(10):1619-28. doi: 10.7150/thno.15344. eCollection 2016.
Zotero 插件